Intellectual Property India Publishes Patent Application for Compositions, Doses, And Methods For Treatment Of Thyroid Eye Disease

MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617085698 A) filed by Viridian Therapeutics, Inc. on July 13, 2026, for Compositions, Doses, And Methods For Treatment Of Thyroid Eye Disease.

Inventors include Bedian, Vahe; Dickinson, Brent; and Foster, Kelly.

The application for the patent was published on September 04, 2026, under issue no. 36/2026.

Abstract: Methods of treating patients with thyroid eye disease are provided for herein, such as by administering subcutaneously antibodies and compositions that bind to and/or antagonize IGF-1R.

Disclaimer: Curated by HT Syndication.